The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, but its legacy within the broader sector now raises questions about future returns . Copycat versions are eroding market share, causing anxieties that betting on companies closely tied to Viagra's once-dominant standing could be a dangerous move , especi